Cerebrolysin in SAH (Subarachnoidal Haemorrhage) - Observational Study

Cerebrolysin in Patients Diagnosed With SAH - an Observational Cohort Study (PILOT)

Subarachnoid haemorrhage often affects people in middle age and is associated with high mortality or neurological damage. In recent years, advances in surgical techniques have im-proved the mortality rate. However, there is still need for the research for the optimal possible final effect of treatment. In our study, we've decided to examine the effect of a multimodal approach including Cerebrolysin in the supportive treatment of patients. We've examined the supply of neuroprotective drugs and neuromonitoring.

Inclusion Criteria:

• age >18 years old, diagnosis of SAH, treatment in ICU conditions

Exclusion Criteria:

• age <18 years, medical history of allergy to Cerebrolysin, acute renal failure, pregnancy, multi organ trauma, death within 48 hours after admission